oxybutynin and pnu 200577

oxybutynin has been researched along with pnu 200577 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inadome, A; Kikukawa, H; Seshita, H; Takahashi, W; Ueda, S; Wada, Y; Yono, M; Yoshida, M1
Chen, A; Dmochowski, R; Gidwani, S; Gupta, S; MacDiarmid, S; Sathyan, G1

Trials

1 trial(s) available for oxybutynin and pnu 200577

ArticleYear
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:8

    Topics: Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Benzhydryl Compounds; Cresols; Cross-Over Studies; Delayed-Action Preparations; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Tolterodine Tartrate

2005

Other Studies

1 other study(ies) available for oxybutynin and pnu 200577

ArticleYear
Pharmacological effects of tolterodine on human isolated urinary bladder.
    European journal of pharmacology, 1999, Mar-05, Volume: 368, Issue:2-3

    Topics: Aged; Benzhydryl Compounds; Benzilates; Calcium Chloride; Carbachol; Cresols; Dose-Response Relationship, Drug; Electric Stimulation; Female; Humans; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Phenylpropanolamine; Potassium Chloride; Tolterodine Tartrate; Urinary Bladder

1999